Mayer Fishman, MD, PhD | Authors


Dr. Mayer Fishman on New Treatment Combination for Patients with Metastatic Chemo-Refractory Urothelial Cancer

October 30, 2015

Mayer Fishman, MD, PhD, Medical Oncologist, Moffitt Cancer Center, talks about the phase Ib/II study of an IL-2/T-cell receptor fusion protein in combination with gemcitabine and cisplatin in advanced or metastatic chemo-refractory urothelial cancer (UC).